Clinical Trial Update: Crossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms in Response to Cat Dander Challenge [Phase 2]

View source ↗

Summary

Phase 2 crossover trial evaluating whether zafirlukast can prevent allergen-induced signs and symptoms after cat dander exposure; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat Allergy

Drugs mentioned

• Zafirlukast (zafirlukast)

Snippet

Sponsor: Allergy & Asthma Medical Group & Research Center | Conditions: Allergy to Cats | Phase 2 | Status: NOT_YET_RECRUITING